La voie de signalisation PI3K-AKT-mTOR : description, développement thérapeutique, résistances, marqueurs prédictifs/pronostiques et applications thérapeutiques en cancérologie
Author:
Publisher
Elsevier BV
Subject
Cancer Research,Radiology Nuclear Medicine and imaging,Oncology,Hematology,General Medicine
Reference45 articles.
1. mTOR-targeted therapy of cancer with rapamycin derivatives;Vignot;Ann Oncol,2005
2. Upstream and downstream of mTOR;Hay;Genes Dev,2004
3. Topics in mTOR pathway and its inhibitors;Dreyer;Bull Cancer,2009
4. Role of the PI3K/AKT and mTOR signaling pathways in acute myeloid leukemia;Park;Haematologica,2010
5. AMPK phosphorylation of raptor mediates a metabolic checkpoint;Gwinn;Mol Cell,2008
Cited by 28 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Exploring the Therapeutic Potential of Ginkgo biloba Polyphenols in Targeting Biomarkers of Colorectal Cancer: An In-silico Evaluation;Current Drug Discovery Technologies;2024-11
2. Combination therapy of acute myeloid leukemia by dual PI3K/mTOR inhibitor BEZ235 and TLR-7/8 agonist R848 in murine model;International Immunopharmacology;2023-12
3. L’antigène membranaire spécifique de la prostate (PSMA) et ses ligands radiomarqués pour la médecine nucléaire;Médecine Nucléaire;2023-10
4. Beneficial and detrimental aspects of miRNAs as chief players in breast cancer: A comprehensive review;International Journal of Biological Macromolecules;2023-01
5. The Effects of PI3K/Akt/mTOR Signaling Pathway Inhibitors on the Expression of Immune Checkpoint Ligands in Acute Myeloid Leukemia Cell Line;Iranian Journal of Allergy, Asthma and Immunology;2022-04-17
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3